1 |
EBAUGH F G, BIRD R M. The normal megakaryocyte concentration in aspirated human bone marrow[J]. Blood, 1951, 6(1): 75-80.
|
2 |
KOUPENOVA M, LIVADA A C, MORRELL C N. Platelet and megakaryocyte roles in innate and adaptive immunity[J]. Circ. Res., 2022, 130(2): 288-308.
|
3 |
BRAUN A, MAMMADOVA-BACH E. GALE force in platelet production[J]. Blood, 2023, 141(4): 330-331.
|
4 |
JUNT T, SCHULZE H, CHEN Z, et al.. Dynamic visualization of thrombopoiesis within bone marrow[J]. Science, 2007, 317(5845): 1767-1770.
|
5 |
LIU C, HUANG B, WANG H, et al.. The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation[J]. Stem Cells Transl. Med., 2021, 10(12): 1614-1620.
|
6 |
MARGRAF A, NUSSBAUM C, SPERANDIO M. Ontogeny of platelet function[J]. Blood Adv., 2019, 3(4): 692-703.
|
7 |
VIEIRA-DE-ABREU A, CAMPBELL R A, WEYRICH A S, et al.. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum[J]. Semin. Immunopathol., 2012, 34(1): 5-30.
|
8 |
XU X R, ZHANG D, OSWALD B E, et al.. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond[J]. Crit. Rev. Clin. Lab. Sci., 2016, 53(6): 409-430.
|
9 |
SHIRAKI R, INOUE N, KAWASAKI S, et al.. Expression of Toll-like receptors on human platelets[J]. Thromb. Res., 2004, 113(6): 379-385.
|
10 |
CUNIN P, NIGROVIC P A. Megakaryocytes as immune cells[J]. J. Leukocyte Biol., 2019, 105(6): 1111-1121.
|
11 |
ZUFFEREY A, SPECK E R, MACHLUS K R, et al.. Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets[J]. Blood Adv., 2017, 1(20): 1773-1785.
|
12 |
BRAY P F, MCKENZIE S E, EDELSTEIN L C, et al.. The complex transcriptional landscape of the anucleate human platelet[J]. BMC Genomics, 2013, 14(1): 1-15.
|
13 |
HARRISON P, GOODALL A H. "Message in the platelet"--more than just vestigial mRNA![J]. Platelets, 2008, 19(6): 395-404.
|
14 |
HILLE L, CEDERQVIST M, HROMEK J, et al.. Evaluation of an alternative staining method using SYTO 13 to determine reticulated platelets[J]. Thromb. Haemost., 2019, 119(5): 779-785.
|
15 |
D'AMBROSI S, NILSSON R J, WURDINGER T. Platelets and tumor-associated RNA transfer[J]. Blood, 2021, 137(23): 3181-3191.
|
16 |
SUN Z Q, XIA M J, ZHENG L, et al.. The biological characteristics and transcriptome changes of platelets in the mouse peritonitis model[J]. Curr. Biotechnol., 2021, 11(3): 378-385.
|
17 |
LIU C, WU D, XIA M, et al.. Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes[J/OL]. Adv. Sci., 2021, 8(15): e2100921[2021-05-26]. .
|
18 |
XIE X, SHI Q, WU P, et al.. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection[J]. Nat. Immunol., 2020, 21(9): 1119-1133.
|
19 |
JIANG H, YU Z, DING N, et al.. The role of AGK in thrombocytopoiesis and possible therapeutic strategies[J]. Blood, 2020, 136(1): 119-129.
|
20 |
EATON N, BOYD E K, BISWAS R, et al.. Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice[J/OL]. Front. Oncol., 2022, 12: 959806[2022-08-30]. .
|
21 |
MANNE B K, DENORME F, MIDDLETON E A, et al.. Platelet gene expression and function in patients with COVID-19[J]. Blood, 2020, 136(11): 1317-1329.
|
22 |
PARISER D N, HILT Z T, TURE S K, et al.. Lung megakaryocytes are immune modulatory cells[J/OL]. J. Clin. Invest., 2021, 131:1[2020-10-20]. .
|
23 |
YEUNG A K, VILLACORTA-MARTIN C, HON S, et al.. Lung megakaryocytes display distinct transcriptional and phenotypic properties[J]. Blood Adv., 2020, 4(24): 6204-6217.
|
24 |
孙志强,夏美娟,郑琳,等.小鼠腹膜炎模型下血小板的生物学特征及其转录组变化[J].生物技术进展,2021,11(3):378-385.
|
25 |
WANG H, HE J, XU C, et al.. Decoding human megakaryocyte development[J]. Cell Stem Cell, 2021, 28(3): 535-549.
|
26 |
SUN S, JIN C, SI J, et al.. Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis[J]. Blood, 2021, 138(14): 1211-1224.
|
27 |
李敏敏,夏美娟,赵晶晶,等.人类胚胎期和成年期巨核细胞的分子特征比较[J].生物技术进展,2022,12(4):577-583.
|